{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T06:06:09Z","timestamp":1792994769952,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12014\/1"],"award-info":[{"award-number":["MC_UU_12014\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["102789\/Z\/13\/A"],"award-info":[{"award-number":["102789\/Z\/13\/A"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jhep.2019.07.025","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:45:23Z","timestamp":1565207123000},"page":"1099-1105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C"],"prefix":"10.1016","volume":"71","author":[{"given":"Kate","family":"Childs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1988-7364","authenticated-orcid":false,"given":"Sarah","family":"Montague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Filipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3882-3339","authenticated-orcid":false,"given":"Lily","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7964-4700","authenticated-orcid":false,"given":"Peter","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Dusheiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2019.07.025_b0005","series-title":"Global hepatitis report","author":"Hutin","year":"2017"},{"key":"10.1016\/j.jhep.2019.07.025_b0010","article-title":"New highly diverse hepatitis C strains detected in sub-Saharan Africa have unknown susceptibility to direct-acting antiviral treatments","author":"Davis","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.025_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(17)30257-1","article-title":"Hepatitis C and the absence of genomic data in low-income countries: a barrier on the road to elimination?","author":"Niebel","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.07.025_b0020","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.025_b0025","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jhep.2017.01.007","article-title":"NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome","volume":"66","author":"Zeuzem","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.025_b0030","unstructured":"HCV Sequence Database, Los Alamos HCV Database. Available at: https:\/\/hcv.lanl.gov\/components\/sequence\/HCV\/geo\/geo.comp. Accessed: 1st May 2019."},{"key":"10.1016\/j.jhep.2019.07.025_b0035","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jhep.2017.11.044","article-title":"Reply to: Reply to: Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries","volume":"68","author":"da Silva Filipe","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.025_b0040","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jhep.2017.07.019","article-title":"Reply to: Response to DAA therapy in the NHS England early access programme for rare HCV subtypes from low and middle income countries","volume":"67","author":"Zeuzem","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.025_b0045","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00330-16","article-title":"Comparison of next-generation sequencing technologies for comprehensive assessment of full-length hepatitis C viral genomes","author":"Thomson","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2019.07.025_b0050","doi-asserted-by":"crossref","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/j.jhep.2019.07.025_b0055","unstructured":"Heinze G, Ploner M. logistf: Firth\u2019s Bias-Reduced Logistic Regression. R package version 1.23. (2018)."},{"key":"10.1016\/j.jhep.2019.07.025_b0060","article-title":"Characterization of full-length hepatitis C virus sequences for subtypes 1e, 1h and 1l, and a novel variant revealed Cameroon as an area in origin for genotype 1","author":"Njouom","year":"2013","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2019.07.025_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2014.07.006","article-title":"Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa","author":"Iles","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2019.07.025_b0070","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","author":"Pawlotsky","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.025_b0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.gastro.2016.06.002","article-title":"Prevalence of resistance-associated substitutions in HCV NS5A, NS5B, or NS3 and outcomes of treatment with ledipasvir and sofosbuvir","volume":"151","author":"Sarrazin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.025_b0080","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hep.30225","article-title":"Frequent antiviral treatment failures in patients infected with hepatitis C virus genotype 4, subtype 4r","volume":"69","author":"Fourati","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.025_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(18)30320-9","article-title":"Direct-acting antiviral treatment in sub-Saharan Africa: a prospective trial of Ledipasvir\/Sofosbuvir for chronic hepatitis C infection in Rwanda (the SHARED study)","author":"Gupta","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.025_b0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26862-y","article-title":"Prevalence of single and multiple natural NS3, NS5A and NS5B resistance-associated substitutions in hepatitis C virus genotypes 1\u20134 in Italy","author":"Bertoli","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2019.07.025_b0095","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz076","article-title":"Identification of 19 novel hepatitis C virus subtypes-further expanding HCV classification","author":"Hedskog","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jhep.2019.07.025_b0100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/jvh.12795","article-title":"Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4","volume":"25","author":"Camus","year":"2018","journal-title":"J Viral Hepatol"},{"key":"10.1016\/j.jhep.2019.07.025_b0105","doi-asserted-by":"crossref","first-page":"e01844","DOI":"10.1128\/JCM.01844-18","article-title":"Susceptibility of hepatitis C virus genotype 1 through 6 clinical isolates to the pangenotypic NS3\/4A inhibitor voxilaprevir","volume":"57","author":"Han","year":"2019","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819304684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819304684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:55:01Z","timestamp":1777510501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827819304684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0168827819304684"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2019.07.025","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2019.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}